PD Dr. oec. troph. Sabrina Schlesinger

Home PD Dr. oec. troph. Sabrina Schlesinger

PD Dr. oec. troph. Sabrina Schlesinger
Deputy Director
Institute for Biometrics and Epidemiology
Head
Research Group Epidemiology
+49 211 3382-231

Selected Publications

  • Baechle C, Stoye FV, Shokri-Mashhadi N, Klötzsch A-T, Bongaerts B, Hoyer A, Kuss O, Landgraf R, Rathmann W, Schlesinger S 2026. Reassessment of the Diagnostic Accuracy of HbA1c and Glucose for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Observational Studies. Diabetes-Metab Res Rev. 42: e70160. https://doi.org/10.1002/dmrr.70160
  • Barbaresko J, Kannenberg L, Schaefer E, Lang A, Schwingshackl L, Neuenschwander M, Schlesinger S 2026. Dietary patterns and cardiovascular diseases in individuals with type 2 diabetes: a systematic review and meta-analysis of prospective observational studies. Adv Nutr. 17. https://doi.org/10.1016/j.advnut.2026.100640
  • Maier GA, Hennig B, Rathmann W, Kuss O 2026. Comparative effectiveness of combination therapy with SGLT-2 inhibitors and GLP-1 RAs compared with SGLT-2 inhibitors in individuals with type 2 diabetes: A prevalent new-user cohort study. Diabetes, Obesity & Metabolism. 28: 3273-3284. https://doi.org/10.1111/dom.70523
  • Stahl-Pehe A, Baechle C, Lanzinger S, Urschitz MS, Holl RW, Rosenbauer J 2025. Type 1 diabetes incidence curves differ by age for girls and boys between 1996 and 2022: Results from the North Rhine-Westphalia Diabetes Registry, Germany. Diabetes Research and Clinical Practice. 220: 111996. https://doi.org/10.1016/j.diabres.2025.111996
  • Schaefer E, Barbaresko J, Roden M, Kuss O, Schlesinger S 2025. Plant-Based Dietary Patterns Associated With Reduced Risk of All-Cause Mortality in Diabetes Subgroups: A Prospective Cohort Study From the UK Biobank. Diabetes Care. 48: 1850-1860. https://doi.org/10.2337/dc25-0344
  • Lang A, Tönnies T, Barbaresko J, Petry SF, Krüger M, Heinemann L, Landgraf R, Franco JV, Bongaerts B, Metzendorf M-I, Schlesinger S 2025. Heat as a prognostic factor for the development and progression of diabetes: a systematic review and meta-analysis. Cochrane Database Syst Rev. 7: CD016289. https://doi.org/10.1002/14651858.CD016289
  • Baechle C, Rosenbauer J, Stahl-Pehe A, Seufert J, Mader JK, Wagner C, Wosch F-J, Erath D, Holl RW, Lanzinger S for the in cooperation with the DPV‐Science initiative, supported by the German Center for Diabetes Research (DZD) 2025. Effectiveness of add-on therapy with SGLT2 inhibitors or GLP-1 receptor agonists in adults with type 1 diabetes: A prospective DPV registry study. Diabetes, Obesity & Metabolism. 27: 1591-1596. https://doi.org/10.1111/dom.16149
  • Wolf K, Bongaerts BWC, Schneider A, Huth C, Meisinger C, Peters A, Schneider A, Wittsiepe J, Schramm K-W, Greiser KH, Hartwig S, Kluttig A, Rathmann W 2019. Persistent organic pollutants and the incidence of type 2 diabetes in the CARLA and KORA cohort studies. Environ Res. 129: 221-228. https://doi.org/10.1016/j.envint.2019.05.030
  • Kowall B, Rathmann W, Bongaerts B, Kuss O, Stang A, Roden M, Herder C, Koenig W, Huth C, Heier M, Thorand B, Ladwig K-H, Holle R, Meisinger C, Peters A 2019. Incidence Rates of Type 2 Diabetes in People With Impaired Fasting Glucose (ADA vs. WHO Criteria) and Impaired Glucose Tolerance: Results From an Older Population (KORA S4/F4/FF4 Study). Diabetes Care. 42: e18-e20. https://doi.org/10.2337/dc18-1473
  • Rathmann W, Strassburger K, Bongaerts B, Kuss O, Müssig K, Burkart V, Szendroedi J, Kotzka J, Knebel B, Al-Hasani H, Roden M for the GDS Group 2019. A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes. Diabetologia. 62: 286-291. https://doi.org/10.1007/s00125-018-4759-z
  • Rathmann W, Strassburger K, Bongaerts B, Bobrov P, Kuss O, Müssig K, Markgraf D, Szendroedi J, Herder C, Roden M for the GDS Group 2017. Impact of Insulin Sensitivity, Beta-cell Function and Glycemic Control on Initiation of Second-Line Glucose-Lowering Treatment in Newly Diagnosed Type 2 Diabetes. Diabetes Obes Metab. 19: 866-873. https://doi.org/10.1111/dom.12894
  • Jacobs E, Hoyer A, Brinks R, Icks A, Kuss O, Rathmann W 2017. Healthcare costs of Type 2 diabetes in Germany. Diabet Med. 34: 855-861. https://doi.org/10.1111/dme.13336
  • Jacobs E, Hoyer A, Brinks R, Kuss O, Rathmann W 2017. Burden of Mortality Attributable to Diagnosed Diabetes: A Nationwide Analysis Based on Claims Data from 65 Million People in Germany. Diabetes Care. 40: 1703-1709. https://doi.org/10.2337/dc17-0954
  • Tamayo T, Brinks R, Hoyer A, Kuss O, Rathmann W 2016. The Prevalence and Incidence of Diabetes in Germany. Dtsch Arztebl Int. 113: 177-82. https://doi.org/10.3238/arztebl.2016.0177
  • Kowall B, Rathmann W, Kostev K 2015. Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis. Diabetes Care. 38: 59-65. https://doi.org/10.2337/dc14-0977
  • Tamayo T, Rosenbauer J, Wild SH, Spijkerman AMW, Baan C, Forouhi NG, Herder C, Rathmann W 2014. Diabetes in Europe: an update. Diabetes Res Clin Pract. 103: 206-17. https://doi.org/10.1016/j.diabres.2013.11.007